# Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis

> **NCT01793519** · PHASE4 · UNKNOWN · sponsor: **Georgetown University** · enrollment: 290 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Infliximab
- **DRUG:** Adalimumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01793519
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-08-30
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01793519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01793519, "Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01793519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*